Headlands Technologies LLC Blueprint Medicines Corp Transaction History
Headlands Technologies LLC
- $939 Million
- Q4 2024
A detailed history of Headlands Technologies LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Headlands Technologies LLC holds 749 shares of BPMC stock, worth $68,353. This represents 0.01% of its overall portfolio holdings.
Number of Shares
749Holding current value
$68,353% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$618 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$607 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$518 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$391 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$228 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.45B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...